These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12975604)

  • 21. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).
    Nicole S; Davoine CS; Topaloglu H; Cattolico L; Barral D; Beighton P; Hamida CB; Hammouda H; Cruaud C; White PS; Samson D; Urtizberea JA; Lehmann-Horn F; Weissenbach J; Hentati F; Fontaine B
    Nat Genet; 2000 Dec; 26(4):480-3. PubMed ID: 11101850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane.
    Groffen AJ; Veerkamp JH; Monnens LA; van den Heuvel LP
    Nephrol Dial Transplant; 1999 Sep; 14(9):2119-29. PubMed ID: 10489220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
    Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
    Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.
    Arikawa-Hirasawa E; Rossi SG; Rotundo RL; Yamada Y
    Nat Neurosci; 2002 Feb; 5(2):119-23. PubMed ID: 11802174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I.
    French MM; Gomes RR; Timpl R; Höök M; Czymmek K; Farach-Carson MC; Carson DD
    J Bone Miner Res; 2002 Jan; 17(1):48-55. PubMed ID: 11771669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perlecan--a multifunctional extracellular proteoglycan scaffold.
    Farach-Carson MC; Carson DD
    Glycobiology; 2007 Sep; 17(9):897-905. PubMed ID: 17442708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perlecan and tumor angiogenesis.
    Jiang X; Couchman JR
    J Histochem Cytochem; 2003 Nov; 51(11):1393-410. PubMed ID: 14566013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perlecan, a heparan sulfate proteoglycan, regulates systemic metabolism with dynamic changes in adipose tissue and skeletal muscle.
    Yamashita Y; Nakada S; Yoshihara T; Nara T; Furuya N; Miida T; Hattori N; Arikawa-Hirasawa E
    Sci Rep; 2018 May; 8(1):7766. PubMed ID: 29773865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.
    Stum M; Girard E; Bangratz M; Bernard V; Herbin M; Vignaud A; Ferry A; Davoine CS; Echaniz-Laguna A; René F; Marcel C; Molgó J; Fontaine B; Krejci E; Nicole S
    Hum Mol Genet; 2008 Oct; 17(20):3166-79. PubMed ID: 18647752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparan sulfate of perlecan is involved in glomerular filtration.
    Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
    J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton.
    Parajuli A; Pei S; Zhao H; Martinez JR; Lu XL; Liu XS; Farach-Carson MC; Kirn-Safran CB; Wang L
    Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32013135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro.
    Gustafsson E; Almonte-Becerril M; Bloch W; Costell M
    PLoS One; 2013; 8(1):e53715. PubMed ID: 23320101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of endogenous perlecan function improves differentiation of rat articular chondrocytes in vitro.
    Nakamura R; Nakamura F; Fukunaga S
    Anim Sci J; 2015 Apr; 86(4):449-58. PubMed ID: 25410015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perlecan maintains the integrity of cartilage and some basement membranes.
    Costell M; Gustafsson E; Aszódi A; Mörgelin M; Bloch W; Hunziker E; Addicks K; Timpl R; Fässler R
    J Cell Biol; 1999 Nov; 147(5):1109-22. PubMed ID: 10579729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular matrices of the avian ovarian follicle. Molecular characterization of chicken perlecan.
    Hummel S; Osanger A; Bajari TM; Balasubramani M; Halfter W; Nimpf J; Schneider WJ
    J Biol Chem; 2004 May; 279(22):23486-94. PubMed ID: 15016830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
    Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
    J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane.
    Goldberg S; Harvey SJ; Cunningham J; Tryggvason K; Miner JH
    Nephrol Dial Transplant; 2009 Jul; 24(7):2044-51. PubMed ID: 19144998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane.
    Groffen AJ; Ruegg MA; Dijkman H; van de Velden TJ; Buskens CA; van den Born J; Assmann KJ; Monnens LA; Veerkamp JH; van den Heuvel LP
    J Histochem Cytochem; 1998 Jan; 46(1):19-27. PubMed ID: 9405491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerosis in perlecan heterozygous mice.
    Vikramadithyan RK; Kako Y; Chen G; Hu Y; Arikawa-Hirasawa E; Yamada Y; Goldberg IJ
    J Lipid Res; 2004 Oct; 45(10):1806-12. PubMed ID: 15258195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.